Latest Kaiser Health News Stories
Democrats had hoped not only to defeat President Donald Trump but also to capture the Senate so they could make major policy changes, such as bolstering the Affordable Care Act and reducing the number of uninsured.
Former Vice President Joe Biden remains on the cusp of being declared the winner of the presidential election, and which party will control the Senate next year remains in question. The outcomes of both the presidential and Senate elections will have dramatic effects on the health agenda. Meanwhile, should President Donald Trump eke out a win, his administration is still pushing some sweeping health changes. Joanne Kenen of Politico, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
In a notable loss for Democrats, Shalala, who represented a Miami district, was defeated by Maria Elvira Salazar — a Republican former TV journalist who compared Democratic policy proposals to leftist oppression in countries like Cuba.
Science is becoming increasingly politicized, so how will it fare on the campaign trail — in 2020 and beyond?
Democratic congressional candidates in California and beyond are linking their Republican opponents to the COVID-19 crisis and the survival of the Affordable Care Act, betting that health care could be a decisive issue for voters, especially in toss-up districts.
Much like President Barack Obama, a President Biden could find his health policies initially sidelined by economic issues — in his case, caused by the pandemic.
Rather than prosecuting their case against Supreme Court nominee Amy Coney Barrett, Democrats on the Senate Judiciary Committee are refighting the war that won them seats in 2018 — banging on Republicans for trying to eliminate the Affordable Care Act.
In less than six years, Sen. Joni Ernst has gone from being a rising star in the Republican Party to running neck and neck against a political newcomer. A poll last month showed more than 1 in 3 Iowa voters think Ernst’s relationship to President Donald Trump is “too close,” and her comments about the coronavirus death toll sparked a backlash.
The CEO of Mallinckrodt Pharmaceuticals defended the price hikes of Acthar gel, an orphan drug that treats infantile spasms at a House Oversight Committee hearing on Thursday.
Democrats on the House Oversight Committee released a damning investigation Wednesday of drug company pricing tactics and profits, as two days of hearings with testimony from pharmaceutical industry CEOs begin.
The term “herd immunity” has found its way into politicized discussions about how to overcome the COVID-19 pandemic. But what does it actually mean? And does it work?
President Donald Trump’s executive order says that people with preexisting conditions can get affordable insurance. But it doesn’t explain how.
The president entered office seeking to overturn the Affordable Care Act, revamp Medicaid and drive down prescription drug prices, among other things. He’s hit some stone walls.
The legislation falls short of the big challenge.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
We’re off this week, but the Affordable Care Act is in the news, as the GOP holds its virtual convention and the Supreme Court recently scheduled arguments in a case challenging the law. So we’re reposting our ACA 10th anniversary episode from March. For this special episode of “What the Health?” host Julie Rovner interviews Kathleen Sebelius, who was President Barack Obama’s secretary of Health and Human Services when the law was passed. Then Rovner, Joanne Kenen of Politico and Mary Agnes Carey of KHN discuss the law’s history, impact and prospects for the future.
Desde que comenzó la pandemia, el Congreso ha reservado miles de millones para aliviar la crisis. Pero parte de ese dinero no se ha distribuido, o gastado, apropiadamente.
Congress has allocated trillions of dollars to ease the coronavirus crisis. A joint KHN and AP investigation finds that many communities with big outbreaks have spent little of that federal money on local public health departments for work such as testing and contact tracing.
Poor information-sharing between hospitals and public health agencies has hurt the response to the pandemic. Some health care systems and IT companies are making inroads, but an overhaul would cost billions.
The Democratic presidential ticket is complete, with Joe Biden’s selection of California Sen. Kamala Harris as his running mate. Health has not been a major issue for Harris, whose career priority has been the criminal justice system. But expect Republicans to pounce on her on-again, off-again support for “Medicare for All.” Meanwhile, with Congress still in a stalemate over another round of COVID-19 relief, President Donald Trump is trying to use his executive power to do what lawmakers have not — with mixed success. Kimberly Leonard of Business Insider, Joanne Kenen of Politico and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.